Compare Medtronic PLC (MDT) vs State Street Real Estate Select Sector SPDR ETF (XLRE) Price & Performance

Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.

The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.

XLRE, the Real Estate Select Sector SPDR ETF, trades at $45.23, down 0.42% on the day, while maintaining a bullish technical trend per moving averages. The fund's low 0.08% expense ratio and 3.4% trailing yield appeal to cost-conscious income investors. Recent news highlights a quiet revival in REIT ETFs, with XLRE gaining 11% year-to-date as of late May 2026, defying broader rate pressures amid shifting Fed expectations.

The outlook for XLRE is cautiously optimistic, supported by solid REIT fundamentals and potential as a geopolitical hedge. Key opportunities include attractive valuations and dividend sustainability, but risks persist from interest rate volatility and inflation concerns that could pressure real estate valuations and investor sentiment in the near term.